5 Stocks to Watch: Week of 3/30/2026

Hey there. We’ve got a swell batch of high-upside-potential stocks to watch this week, including:

• SanDisk (NASDAQ: SNDK) enjoys solid demand 
• Jazz Pharmaceuticals (NASDAQ: JAZZ) has over 50% potential upside in the coming year
• Infinity Natural Resources Inc (INR) — $1.2B acquisition fuels Appalachian Basin growth surge
• MNTN Inc (MNTN) — Analysts see 200%+ upside in Performance TV play
• MYR Group (MYRG) — #1 ranked infrastructure stock riding grid modernization wave
• Missed last week's picks? Get them here

A note from our sponsors...

1- SanDisk (NASDAQ: SNDK)

SanDisk is a NAND flash storage powerhouse behind SSDs, embedded tech, and removable storage. After a jaw-dropping 1,200% run fueled by AI hype, it’s now at the center of a high-stakes question: real demand—or a bubble about to burst?

Zen Rating: A (Strong Buy) — see full analysis

Recent Price: $605.40 — get current quote

Max 1-year forecast: $900

Why we're watching:

• Analyst support: SNDK enjoys 9 Strong Buy ratings, 3 Buy ratings, and 4 Hold ratings. See the ratings
• Citigroup researcher Asiya Merchant (a top 1% rated analyst) recently maintained her Strong Buy rating with an $875.00 price target; Cantor Fitzgerald researcher C.J. Muse (a top 3% rated analyst) recently maintained his Strong Buy rating with an $800.00 price target, demonstrating continued confidence in the company's positioning.
• Revenue is forecast to explode +74.35% to $15.6B in the coming year, with two-year growth projections of +198.22%, driven by surging AI infrastructure demand for high-performance storage solutions.
• Industry ranking context: SNDK is currently the #1 highest-rated stock in the Computer Hardware industry — but note that this market niche has an Industry Rating of D.
• Zen Rating highlights: Strong Buy (A) stocks average +32.52%/yr, and SNDK's momentum continues to attract top-tier analyst support despite concerns about valuation.
• Component Grades: The company demonstrates exceptional growth credentials with an A rating in Growth and Sentiment, complemented by B ratings in Momentum and Financials, though Value and Safety receive C ratings reflecting elevated valuation concerns. See all 7 Zen Component Grades here

2- Jazz Pharmaceuticals (NASDAQ: JAZZ)

Jazz Pharmaceuticals is a global biopharma player targeting high-need diseases. With promising oncology data heading into AACR 2026 and strong analyst backing, the stock sits near its lows—setting up a potential upside surprise.

Zen Rating: A (Strong Buy) — see full analysis

Recent Price: $189.22 — get current quote

Max 1-year forecast: $275.00

Why we're watching:

• Analyst support: JAZZ enjoys 7 Strong Buy ratings, 3 Buy ratings, and 1 Hold rating, resulting in a Strong Buy consensus. See the ratings here
• Bank of America researcher Jason Gerberry (a top 15% rated analyst) recently maintained his Strong Buy rating with a $275.00 price target (+45.44% upside), the highest on the Street.
• Wells Fargo researcher Mohit Bansal (a top 15% rated analyst) recently maintained his Strong Buy rating with a $250.00 price target following recent conference presentations.
• The company demonstrates strong profitability with a 17% profit margin and robust return on equity of 44.06%, while revenue is expected to grow +6.17% to $4.5B with improving earnings trajectory.
• Industry ranking context: JAZZ is currently the 5th highest-rated stock in the Biotech industry, which has an Industry Rating of F, making it a standout performer in a challenging sector.
• Zen Rating highlights: As an A-rated stock, JAZZ ranks in the top 5% of the 4,600+ stocks we track, with outstanding fundamentals: It boasts a Component Grade of A for Growth, complemented by B ratings in Value, Financials, and AI. See all 7 Zen Component Grades here

A note from our sponsors...

3- Mntn Inc (NYSE: MNTN)

MNTN Inc lets brands bring the precision of digital advertising to the big screen through its Performance TV platform. With eight analysts tracking the stock and a consensus price target implying over 200% upside, Wall Street is betting big on MNTN's growing momentum in connected TV.

Zen Rating: Strong Buy (A) — see full analysis

Recent Price: $8.75 — get current quote

Max 1-year forecast: $27.00

Why we're watching:

• Analyst support: MNTN commands mighty Wall Street attention with 4 Strong Buy ratings, 3 Buy ratings, and 1 Hold rating, representing a Strong Buy consensus. See the ratings
• Noteworthy related to the above: Evercore ISI Group's Mark Mahaney set a price target suggesting +213.59% upside. 
• It’s our Stock of the Week: Our Zen Investor Editor-in-Chief just spotlighted the stock as having the potential to TRIPLE in the coming year. See his commentary here. 
• Metrics support the bull case: Revenue growth is accelerating with analysts forecasting $357.3M in revenue for the next fiscal year, representing 23% year-over-year growth, with the company's 18.92% revenue growth rate exceeding both industry (16.09%) and market (13.36%) averages.
• Industry ranking context: MNTN is currently the 3rd highest-rated stock in the App industry, which has an Industry Rating of B.
• Zen Rating highlights: Strong Buy (A) stocks average +32.52%/yr. The company demonstrates exceptional momentum in Performance TV advertising with strong institutional backing across top-tier analysts.
• Component Grades: MNTN exhibits particularly strong Financials (A) and Sentiment (A) grades, complemented by solid Value (B) and Growth (B) ratings, reflecting robust financial health despite current net losses and significant upside potential. See all 7 Zen Component Grades here

4- Myr Group (NASDAQ: MYRG)

MYR Group is the #2 ranked stock in the Engineering & Construction industry — and for good reason. With grid modernization and renewable energy driving massive infrastructure demand, analysts are projecting double-digit earnings growth as MYRG powers projects across the U.S. and Canada.

Zen Rating: Strong Buy (A) — see full analysis

Recent Price: $272.12 — get current quote

Max 1-year forecast: $311.00

Why we're watching:

• Analyst support: MYRG enjoys strong Wall Street conviction among the analysts we track — 3 Strong Buy ratings and 1 Hold rating, yielding a Strong Buy consensus. See the ratings
• Stifel Nicolaus analyst Brian Brophy recently maintained his Strong Buy rating with a $305 price target, highlighting the company's strong positioning in critical infrastructure markets.
• Awesome price action: The stock has surged +191% from its 52-week low of $97.72, reflecting strong execution and pretty darned favorable market dynamics. 
• The move might not be over: Earnings momentum is exceptional with analysts forecasting EPS of $9.28 for the next fiscal year, representing 22.6% year-over-year growth, and the company's return on equity of 37.99% significantly exceeds the industry average of 26.56%.
• That’s not all. Revenue projections show steady growth to $4.1B next year (+11.87%) and $4.4B in two years (+21.35%), driven by robust demand in transmission and distribution infrastructure.
• Industry ranking context: MYRG is currently the 2nd rated stock in the Engineering & Construction industry, which has an Industry Rating of A.
• Zen Rating highlights: Strong Buy (A) stocks average +32.52%/yr. The company demonstrates exceptional performance as one of the top-ranked stocks in its industry with superior profitability metrics.
• Component Grades: MYRG exhibits outstanding Growth (A) performance with solid supporting grades including Value (C), Momentum (B), Sentiment (B), Safety (B), and Financials (B), reflecting balanced strength across key investment factors. See all 7 Zen Component Grades here

5- Infinity Natural Resources Inc (NYSE: INR)

Infinity Natural Resources is scaling fast. After closing a transformational $1.2 billion Antero acquisition in early 2026, securing a $350 million strategic equity investment, and upsizing a senior notes offering to $550 million on strong investor demand, this Appalachian Basin operator is signaling it's just getting started.

Zen Rating: A (Strong Buy) — see full analysis

Recent Price: $18.25 — get current quote

Max 1-year forecast: $24.00

Why we're watching:

• Analyst support: The stock enjoys unanimous bullish coverage with 3 total analysts all maintaining Strong Buy ratings, resulting in a Strong Buy consensus with significant upside potential. See the ratings
• Citigroup researcher Paul Diamond (a top 18% rated analyst) recently maintained his Strong Buy rating while raising his price target to $24.00 (+34.91% upside), citing improving efficiencies and growth opportunities despite only modestly positive Q4 results.
• Diamond highlighted the company's top-tier operating margins within the Appalachian Basin, strong production and Adjusted EBITDAX growth, and decreasing D&C costs per foot as key drivers of future performance.
• Recent geopolitical developments in the Middle East have strengthened crude prices, providing additional tailwinds for the company's operations and cash flow generation.
• The company reported an impressive 26.1% profit margin and 72.36% return on equity, with revenue forecast to surge +72.08% to $613.4M and earnings expected to more than triple to $2.97 per share.
• Industry ranking context: INR is currently the #1 highest-rated stock in the Oil and Gas industry. (Though note that it has an Industry Rating of D, making it a standout performer in a difficult sector.)
• Zen Rating highlights: INR's combination of operational excellence and strategic positioning has earned it an overall A (Strong Buy) rating, putting it in the top 5% of the 4600+ stocks we track based on fundamentals. 
• Component Grades: Infinity demonstrates solid fundamentals with B ratings across Value, Growth, Sentiment, and AI. See all 7 Zen Component Grades here

What to Do Next?

• 77 Best Stocks NOW! >
• Options Trading with the Zen Ratings >
• 2 New Stocks to Buy from Steve Reitmeister >

Want to get in touch? Email us at news@wallstreetzen.com.